Video Experimental Relacionado
Updated: Sep 10, 2025
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
621
Cómo cambió el manejo de tumores musculoesqueléticos durante la pandemia de COVID-19: datos de una encuesta de
Takeshi Morii1, Shintaro Iwata2, Kensaku Yamaga3
1Department of Orthopaedic Surgery, School of Medicine, Kyorin University, 6-20-2 Shinkawa, Mitaka-shi 181-8611, Tokyo, Japan.
Current oncology (Toronto, Ont.)
|August 27, 2025
Resumen
La pandemia de COVID-19 interrumpió significativamente la atención de la oncología musculoesquelética en Japón, lo que afectó los servicios ambulatorios y las cirugías. Las infecciones directas de los pacientes fueron la causa principal de los cambios en las estrategias de tratamiento de los tumores óseos y de los tejidos blandos.
Área de la Ciencia:
- En el campo de la oncología
- Epidemiología
- Gestión de la asistencia sanitaria
Sus antecedentes:
- Existen datos limitados sobre el impacto de COVID-19 en el cuidado de tumores óseos y de tejidos blandos en Japón.
- Los estudios anteriores se centraron ampliamente en los cambios en la práctica clínica durante la pandemia.
Objetivo del estudio:
- Para investigar los efectos de la pandemia de COVID-19 en el cuidado de tumores musculoesqueléticos en Japón.
- Identificar los factores que influyen en los cambios en las estrategias de tratamiento.
Principales métodos:
- Encuesta nacional basada en la web de hospitales especializados en tumores musculoesqueléticos.
- Evaluó los eventos relacionados con el COVID-19, los retrasos en el tratamiento y las modificaciones en la estrategia de manejo.
Principales resultados:
- 78 hospitales respondieron, reportando infecciones de pacientes (28.2%), agrupaciones de brotes (48.7%) y infecciones de personal (53.8%).
- Las derivaciones de pacientes disminuyeron significativamente; el tratamiento quirúrgico se vio más afectado que la quimioterapia o la radioterapia.
- El 48,7% de los hospitales retrasó o canceló las cirugías; el 20,5% prolongó los intervalos de seguimiento.
Conclusiones:
- La pandemia de COVID-19 interrumpió sustancialmente los servicios de oncología musculoesquelética, particularmente la atención ambulatoria y las cirugías.
- Las infecciones directas de los pacientes se asociaron significativamente con modificaciones en las políticas de tratamiento institucional.
Videos de Conceptos Relacionados
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:21Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:29Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
01:21Inflammatory Bowel Disease V: Surgical Management
212
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
212